These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31327462)

  • 1. Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated β-Catenin Activation.
    Zhang W; Su X; Li S; Wang Y; Wang Q; Zeng H
    Am J Med Sci; 2019 Sep; 358(3):227-234. PubMed ID: 31327462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy.
    Li Z; Sun Y; Qu M; Wan H; Cai F; Zhang P
    Oncotarget; 2017 Jan; 8(2):2906-2915. PubMed ID: 27926520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.
    Lim S; Saw TY; Zhang M; Janes MR; Nacro K; Hill J; Lim AQ; Chang CT; Fruman DA; Rizzieri DA; Tan SY; Fan H; Chuah CT; Ong ST
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):E2298-307. PubMed ID: 23737503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin.
    Xu Y; Liao S; Wang L; Wang Y; Wei W; Su K; Tu Y; Zhu S
    Cancer Chemother Pharmacol; 2021 Jan; 87(1):85-93. PubMed ID: 33159561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective and effective suppression of pancreatic cancer through MNK inhibition.
    Li H; Yao Y; Hao R; Long C
    Immunopharmacol Immunotoxicol; 2024 Aug; ():1-11. PubMed ID: 39138614
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition MNK-eIF4E-β-catenin preferentially sensitizes gastric cancer to chemotherapy.
    Yang X; Liu Z; Yin X; Zeng Y; Guo G
    Fundam Clin Pharmacol; 2022 Aug; 36(4):712-720. PubMed ID: 35048413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of MNK/eIF4E overcomes chemoresistance in cervical cancer.
    Zhu Y; Wang C; Li M; Yang X
    J Pharm Pharmacol; 2021 Sep; 73(10):1418-1426. PubMed ID: 34254647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
    Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
    Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis.
    Li J; Huang Y; Gao Y; Wu H; Dong W; Liu L
    Biochem Biophys Res Commun; 2016 Apr; 472(2):299-305. PubMed ID: 26944016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
    Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.
    Wang W; Wen Q; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Li J; Zhou J; Fan S
    Theranostics; 2017; 7(7):2134-2149. PubMed ID: 28656063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evidence that MNK/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR inhibitor in renal cell carcinoma.
    Chen S; Cui L; Hu Q; Shen Y; Jiang Y; Zhao J
    Biochem Biophys Res Commun; 2020 Sep; 530(1):142-148. PubMed ID: 32828276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral Drug Ribavirin Targets Thyroid Cancer Cells by Inhibiting the eIF4E-β-Catenin Axis.
    Shen X; Zhu Y; Xiao Z; Dai X; Liu D; Li L; Xiao B
    Am J Med Sci; 2017 Aug; 354(2):182-189. PubMed ID: 28864377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy.
    Grzmil M; Seebacher J; Hess D; Behe M; Schibli R; Moncayo G; Frank S; Hemmings BA
    Cell Signal; 2016 Sep; 28(9):1412-1421. PubMed ID: 27289018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Mnk-eIF4E pathway sensitizes the efficacy to chemotherapy in anaplastic thyroid cancer.
    Hu K; Zhang J; Yu M; Xiong C
    Future Oncol; 2017 Mar; 13(6):489-498. PubMed ID: 27785922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines.
    Ramalingam S; Gediya L; Kwegyir-Afful AK; Ramamurthy VP; Purushottamachar P; Mbatia H; Njar VC
    Oncotarget; 2014 Jan; 5(2):530-43. PubMed ID: 24504069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the eIF4E/β-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy.
    Xu H; Wang Z; Xu L; Mo G; Duan G; Wang Y; Sun Z; Chen H
    Am J Transl Res; 2017; 9(3):1203-1212. PubMed ID: 28386346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.